Denosumab (dmab) Treatment for 6 Years Maintains Low Fracture Incidence in Women >= 75 Years With Postmenopausal Osteoporosis (pmo)
Year: 2013
Type: article
Language: English
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3047374615
